What Causes Keratoconus: Genetic, Environmental, and Demographic Factors Compared Across Regions

Genetic Predisposition Across Populations

Keratoconus is a progressive thinning and steepening of the cornea that leads to irregular astigmatism and visual distortion. Family studies consistently show a higher incidence among first‑degree relatives, indicating a strong hereditary component. However, the magnitude of familial clustering varies widely between ethnic groups, suggesting that both shared genes and shared environment contribute to the observed patterns.

Several candidate genes — such as VSX1, SOD1, ZNF469, and TGFBI — have been linked to corneal biomechanics and extracellular‑matrix regulation. Allele frequencies for pathogenic variants in these genes differ markedly: for example, VSX1 mutations appear more often in Middle Eastern cohorts, while ZNF469 variants are enriched in European‑ancestry populations. Genome‑wide association studies have also identified loci near COL5A1 and FOXO1 that show population‑specific effect sizes.

Twin and adoption studies estimate heritability between 0.6 and 0.8, but the proportion of variance explained by known variants remains modest. In regions with high consanguinity, such as parts of the Arabian Peninsula, the recurrence risk in siblings can exceed 20 %, whereas in outbred Northern European cohorts the sibling risk is closer to 5 %. These disparities underscore the importance of local genetic architecture when assessing individual risk.

Environmental Triggers in Urban vs Rural Settings

Mechanical stress from chronic eye rubbing is the most reproducible environmental risk factor. Rubbing is often driven by allergic conjunctivitis, which itself is more prevalent in urban areas with higher levels of airborne pollutants, dust mites, and indoor allergens. Studies from large metropolitan centers in Asia and Europe report eye‑rubbing frequencies two to three times higher than in comparable rural communities.

Ultraviolet (UV) radiation exposure shows a paradoxical relationship. High ambient UV in equatorial rural zones may accelerate corneal collagen cross‑linking, potentially offering a protective stiffening effect, whereas urban dwellers often experience reduced outdoor UV but increased exposure to blue‑light screens and air‑conditioned environments that dry the ocular surface. Both pathways can promote inflammation and matrix degradation.

Occupational and lifestyle factors add another layer. Contact‑lens wear, especially rigid gas‑permeable lenses fitted poorly, is more common in urban professional groups and has been associated with micro‑trauma to the corneal apex. Conversely, agricultural workers in rural settings may experience higher rates of ocular trauma from plant material, yet the overall keratoconus prevalence remains lower, suggesting that trauma alone is insufficient without a susceptible genetic background.

Age‑Related Onset Patterns

The classic presentation emerges during the second decade of life, with the steepest progression between ages 15 and 25. Puberty‑related hormonal surges, rapid ocular growth, and increased academic near‑work coincide, creating a window of biomechanical vulnerability. Longitudinal cohorts from North America and East Asia show a peak incidence at 18–20 years, after which new diagnoses decline sharply.

Pediatric keratoconus, diagnosed before age 12, is rare but tends to be more aggressive, often requiring early surgical intervention. In contrast, late‑onset cases after age 40 usually progress slowly and may be mistaken for age‑related corneal changes. The age distribution shifts in populations with earlier puberty onset, such as certain South Asian groups, where the diagnostic peak can appear as early as 13–14 years.

Hormonal milestones beyond puberty also matter. Pregnancy‑associated increases in estrogen and relaxin have been linked to transient corneal steepening, and a small subset of women experience permanent progression during or after gestation. Menopause‑related hormonal decline does not appear to trigger new onset but may modify progression rates in established disease.

Sex and Hormonal Influences

Epidemiologic surveys from multiple continents report a modest male predominance, typically a 1.2:1 to 1.5:1 male‑to‑female ratio. However, this ratio narrows or reverses in regions where atopic disease is more common in females, such as parts of Scandinavia, suggesting that sex‑specific environmental exposures can offset any intrinsic biological bias.

Estrogen receptors are present in corneal keratocytes, and experimental data indicate that estrogen can modulate collagen synthesis and matrix metalloproteinase activity. Fluctuations during the menstrual cycle, oral‑contraceptive use, and hormone‑replacement therapy have all been examined, but clinical studies yield inconsistent results, likely because hormonal effects interact with genetic susceptibility and mechanical stress.

Pregnancy provides a natural experiment: several case series document new‑onset or accelerated keratoconus during the second and third trimesters, with partial regression postpartum. The magnitude of change correlates with baseline corneal thickness and the presence of allergic eye disease, reinforcing the concept of a multifactorial threshold rather than a single hormonal trigger.

Ethnic and Geographic Variation

Population‑based prevalence estimates range from 0.05 % in Northern European cohorts to over 2 % in certain Middle Eastern and South Asian groups. The highest reported rates come from Saudi Arabia, Iran, and India, where consanguineous marriage practices amplify recessive risk alleles. In contrast, East Asian populations (e.g., Japan, Korea) show intermediate prevalence around 0.3–0.5 % despite high myopia rates, indicating that myopia alone does not drive keratoconus frequency.

Founder effects have been documented in isolated communities. A specific VSX1 mutation accounts for a disproportionate share of cases in a Bedouin tribe, while a COL5A1 haplotype is enriched in a Finnish sub‑population. Migration studies reveal that first‑generation immigrants retain the prevalence of their country of origin, but second‑generation individuals raised in low‑prevalence environments exhibit rates approaching the host population, highlighting gene‑environment interplay.

Geographic gradients also appear within large countries. In the United States, prevalence is higher in the Southwest and among Hispanic communities, paralleling higher rates of atopic disease and UV exposure. In Australia, urban centers with large immigrant populations from high‑prevalence regions show clustered case numbers, whereas rural Indigenous communities report very low incidence.

Comorbid Conditions and Their Regional Prevalence

Atopic disorders — allergic rhinitis, asthma, eczema, and vernal keratoconjunctivitis — are the most consistent systemic companions of keratoconus. The odds ratio for keratoconus in individuals with severe atopy ranges from 3 to 6 across studies. Regions with high atopy burdens, such as the United Kingdom, New Zealand, and parts of the Middle East, consequently display elevated keratoconus rates.

Connective‑tissue syndromes (e.g., Ehlers‑Danlos, Marfan, brittle cornea syndrome) confer a markedly higher risk, but their low overall prevalence limits population impact. Down syndrome stands out: up to 15 % of individuals with trisomy 21 develop keratoconus, a rate far exceeding the general population. The prevalence of Down syndrome is relatively uniform globally, yet access to screening varies, affecting detected case numbers.

Metabolic and inflammatory conditions such as diabetes mellitus and thyroid disease have been explored as modifiers. Diabetic corneal neuropathy may reduce protective blinking and increase rubbing behavior, while thyroid‑associated orbitopathy can alter corneal biomechanics. The contribution of these comorbidities differs by region according to the local prevalence of metabolic syndrome and iodine deficiency.